Joshua Hexter's most recent trade in Oramed Pharmaceuticals, Inc was a trade of 48,500 Common Stock done . Disclosure was reported to the exchange on Feb. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 48,500 | 799,833 (4%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 45,000 | 751,333 (4%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 33,334 | 833,167 (4%) | 0% | 0 | Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 194,500 | 706,333 (3%) | 1% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 30,000 | 511,833 (2%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Hexter Joshua | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 180,500 | 481,833 (2%) | 1% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 27,000 | 301,333 (1%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 108,000 | 274,333 (1%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 42,000 | 166,333 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 36,000 | 36,000 | - | - | Stock Option (right to buy) | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO & CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 21,000 | 124,333 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | Chief Operating & BO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2021 | 33,333 | 103,333 (0%) | 0% | - | Common Stock | |
| Oramed Pharmaceuticals, Inc | Joshua Hexter | COO, Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) |